RE: RNS28 Aug 2021 12:38
Doing some research on N4P at the mo.
Can any LTH kindly explain to me what the USP of N4P is over other existing competitors, in particular, Nuvec as a delivery system over other competitors, i.e. why should big pharma use Nuvec over existing products out there. During Christmas, from what I saw on an IG video, it was the fact that Nuvec could deliver the C19 vaccine at a manageable temperature. Now that issue does not seem have been been overcome, what else is Nuvec's USPs. Tqvm.